EPIDEMIOLOGICAL, SOCIAL AND ECONOMIC EVIDENCES OF VACCINATION AGAINST HUMAN PAPILLOMAVIRUS INFECTION IN SAINT-PETERSBURG

Cover Page


Cite item

Full Text

Abstract

Abstract. Analysis of anogenital warts morbidity in St. Petersburg and Russian Federation in 2000–2013 has been carried out. The incidence rate in the population of St. Petersburg during the observation period was found to be 1.4–2.3 times higher. In 2011–2013, 3310 pregnant women were tested for high carcinogenic risk HPV by PCR. Prevalence rate of HPV genotype 16 was 11.0 per 100 tested persons. Other genotypes (31, 52, 33, 45, 58, 39, 18, 59, 35)were determined less often (p < 0.001) 6.3; 6.3; 5.1; 4.02; 3.7; 3.4; 2.9; 2.8 and 2.7 per 100 persons, respectively. An increased morbidity of cervical cancer in women aging from 25 to 49 years old was established. Assessment of the economic burden of diseases associated with HPV has shown that in 2012 in St. Petersburg expenses were more than one billion rubles. In the structure of economic lost the largest proportion was associated with premature mortality of women with cervical cancer.

About the authors

L. V. Lyalina

St. Petersburg Pasteur Institute, St. Petersburg

Author for correspondence.
Email: lyalina@pasteurorg.ru

PhD, MD (Medicine), Head of Laboratory of Epidemiology

197101, Russian Federation, St. Petersburg, Mira str., 14

 

Россия

References

  1. Вакцины для профилактики рака шейки матки. Под ред. П.Л. Стерна, Г.С. Китченера; пер. с англ.; под общей редакцией академика РАМН Г.Т. Сухих, проф. В.Н. Прилепской. — М.: МЕДпресс-информ, 2009. — 192 с. Vaktsiny dlya profilaktiki raka sheyki matki. (Pod red. P.L. Sterna, G.S. Kitchenera; per. s angl.; pod obshchey redaktsiey akademika RAMN G.T. Sukhikh, prof. V.N. Prilepskoy) [Vaccines for the Prevention of Cervical Cancer. Ed. by P.L. Stern, H.C. Kitchener]. Moscow «MEDpress-inform, 2009, 192 p.
  2. Лялина Л.В., Ахметзянов И.М., Николаевич М.С. Социальное и экономическое обоснование вакцинопрофилактики папилломавирусной инфекции / Под ред. О.Е. Сергеева. — СПб.: ИЦ Эдиция, 2010. — 110 с. Lyalina L.V., Akhmetzyanov I.M., Nikolaevich M.S. Sotsial`noe i ekonomicheskoe obosnovanie vaktsinoprofilaktiki papillomavirusnoy infektsii (pod red. O.E. Sergeeva) [Social and economic evidence of vaccination against Human Papillomavirus Infection (ed. O.E. Sergeev)]. St. Petersburg: Ediziya, 2010, 110 p.
  3. Лялина Л.В., Игнатьева М.Е., Касаткин Е.В., Стебелько О.Ю. Эпидемиология и вакцинопрофилактика папилломавирусной инфекции и злокачественных новообразований, ассоциированных с вирусом папилломы человека: аналитический обзор. — СПб.: Изд-во ФБУН НИИЭМ имени Пастера, 2012. — 68 с. Lyalina L.V., Ignat`eva M.E., Kasatkin E.V., Stebel`ko O.Yu. Epidemiologiya i vaktsinoprofilaktika papillomavirusnoy infektsii i zlokachestvennykh novoobrazovaniy, assotsiirovannykh s virusom papillomy cheloveka: analiticheskiy obzor [Epidemiology and vaccination against Human papillomavirus infection and HPV-associated cancers: analytical review]. St. Petersburg Pasteur Institute, 2012, 68 p.
  4. Мерабишвили В.М. Онкологическая служба Санкт-Петербурга (оперативная отчетность за 2011–2012 гг., углубленная разработка базы данных регистра по международным стандартам). Популяционный раковый регистр (IARC № 221), том 18 / Под ред. В.М. Колабутина, А.М. Беляева. — СПб.: ООО «Издательско-полиграфическая компания «КОСТА», 2013. — 368 с. Merabishvili V.M. Onkologicheskaya sluzhba Sankt-Peterburga (operativnaya otchetnost` za 2011-2012 gody, uglublennaya razrabotka bazy dannykh registra po mezhdunarodnym standartam). Populyatsionnyy rakovyy registr (IARC № 221), tom 18 (pod red. V.M. Kolabutina, A.M. Belyaeva) [Cancer Incidence in St. Petersburg (operative report for 2011–2012, precise elaboration of the Registrys Database by international standards] Population-based Cancer Registry (IARC No. 221) Sci. publ. No. 18. (eds. V.M. Kolabutin, A.M. Belyaev)]. St. Petersburg: KOSTA, 2013, 368 p.
  5. Состояние онкологической помощи населению России в 2012 г. / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. — М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2013. — 232 с. Sostoyanie onkologicheskoy pomoshchi naseleniyu Rossii v 2012 godu (pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoy) [Condition of oncological help to population of Russia in 2012 (ed. by A.D. Kaprin, V.V. Starinaky, G.V. Petrova)]. Moscow: MSROI named after P.A. Gertsen Ministry of Health Russia, 2013, 232 p.
  6. Bresse X., Goergen C., Prager B., Joura E. Universal vaccination with the quadrivalent HPV vaccine in Austria: Impact on virus circulation, public health and cost-effectiveness analysis. www. expert-reviews.com.
  7. Cancer Research for Cancer Control. IARC WHO, 2001, 36 p.
  8. Donovan B., Franklin N., Guy R., Grulich A.E., Regan D.G., Ali H., Wand H., Fairley C.K. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance date. Lancet Infect. Dis., 2011, vol. 11, pp. 39–44.
  9. Giuliano A.R. New evidence for vaccination of males. EUROGIN 2011 «HPV Associated Diseases and Cancer from Reality Now to the Future». Lisbon, Portugal, May 8–11, 2011, p. 60.
  10. Zur Hausen H. Papilomaviruses in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res., 1989, vol. 49, pp. 4677–4681.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Lyalina L.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.